NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDAvelumab 20mg/mL Bavencio®
(Concentrate for infusion) 		Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Avelumab  Avelumab [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Monoclonal Antibodies
Antibody Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1120: Avelumab with axitinib for untreated advanced renal cell carcinoma (replaces TA645)
NICE TA517: Avelumab for treating metastatic Merkel cell carcinoma
NICE TA645 Avelumab with axitinib for untreated advanced renal cell carcinoma (replaced by TA1120)
NICE TA645: Avelumab with axitinib for untreated advanced renal cell carcinoma (replaced by TA1120)
NICE TA691 Avelumab for untreated metastatic Merkel cell carcinoma
NICE TA788 Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy